Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
According to a recent study published in the New England Journal of Medicine an experimental drug for ALS/Lou Gehrig’s disease has slowed the neurological decline, offering hope to a population that is in need of new treatment options. Patients who received the drug in the closely monitored clinical trial are reported to have retained a …
Researchers from the University of Bath have conducted a study that provides new insights into a protein that is associated with brain diseases and dementia. The study observed the ways in which it enters the central nervous system cells as published in the journal PLOS ONE. The workings of angiogenin-a protein were examined by the …
Researchers find that a lack of the hormone melatonin is associated with the progression of an animal model of the neurodegenerative disease amyotrophic lateral sclerosis. New research suggests that the sleep hormone melatonin may prove useful in the treatment of the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS). Robert Friedlander, M.D., Professor of neurosurgery and …